| Filed On | Filing |
|---|---|
| 21 Sep 2026 |
Form 3: Westlake BioPartners Fund I, L.p., 10% owner and 3 others
Holds 3,527,136 shares of Common Stock |
| 18 Sep 2026 | Form 3: Clark Christopher William, Chief Financial Officer |
| 18 Sep 2026 | Form 3: Tucker David J., Principal Accounting Officer |
| 18 Sep 2026 | Form 3: Parry Graham, Chief Scientific Officer |
| 18 Sep 2026 | Form 3: Parry Graham, Principal Accounting Officer |
| 18 Sep 2026 | Form 3: Koe Gary S., Chief Technical Officer |
| 18 Sep 2026 | Form 3: Dong Quehuong (Kathy), Director |
| 18 Sep 2026 | Form 3: Dao Kim-Hien, Chief Medical Officer |
| 18 Sep 2026 | Form 3: Stagliano Nancy, Director |
| 18 Sep 2026 | Form 3: Fust Matthew K, Director |
| 18 Sep 2026 | Form 3: Gordon Carl L, Director |
| 18 Sep 2026 | Form 3: Orbimed Advisors Llc, Director and 2 others |
Loading...
